EMEugene Mahon

Eugene Mahon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eugene Mahon has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Characterization of Nanoparticle Batch-To-Batch Variability

    by Sonja Mülhopt, Silvia Diabaté, Marco Dilger, Christel Adelhelm, Christopher Anderlohr, Thomas Bergfeldt, Johan Gómez de la Torre, Yunhong Jiang, Eugenia Valsami-Jones, Dominique Langevin, et al.

    A central challenge for the safe design of nanomaterials (NMs) is the inherent variability of NM properties, both as produced and as they interact with and evolve in, their surroundings. This has led to uncertainty in the literature regarding whether the biological and toxicological effects reported for NMs are related to specific NM properties themselves, or rather to the presence of impurities or physical effects such as agglomeration of particles. Thus, there is a strong need for systematic evaluation of the synthesis and processing parameters that lead to potential variability of different NM batches and the reproducible production of commonly utilized NMs. The work described here represents over three years of effort across 14 European laboratories to assess the reproducibility of nanoparticle properties produced by the same and modified synthesis routes for four of the OECD priority NMs (silica dioxide, zinc oxide, cerium dioxide and titanium dioxide) as well as amine-modified polystyrene NMs, which are frequently employed as positive controls for nanotoxicity studies. For 46 different batches of the selected NMs, all physicochemical descriptors as prioritized by the OECD have been fully characterized. The study represents the most complete assessment of NMs batch-to-batch variability performed to date and provides numerous important insights into the potential sources of variability of NMs and how these might be reduced.


  • Open Access

    Tuning of nanoparticle biological functionality through controlled surface chemistry and characterisation at the bioconjugated nanoparticle surface

    by Delyan R. Hristov, Louise Rocks, Philip M. Kelly, Steffi S. Thomas, Andrzej S. Pitek, Paolo Verderio, Eugene Mahon, Kenneth A. Dawson

    We have used a silica – PEG based bionanoconjugate synthetic scheme to study the subtle connection between cell receptor specific recognition and architecture of surface functionalization chemistry. Extensive physicochemical characterization of the grafted architecture is capable of capturing significant levels of detail of both the linker and grafted organization, allowing for improved reproducibility and ultimately insight into biological functionality. Our data suggest that scaffold details, propagating PEG layer architecture effects, determine not only the rate of uptake of conjugated nanoparticles into cells but also, more significantly, the specificity of pathways via which uptake occurs.


  • Controlling aqueous silica nanoparticle synthesis in the 10–100 nm range

    by Delyan R. Hristov, Eugene Mahon, Kenneth A. Dawson

    Controlling monomer generation rate in different ways, we broaden the range of sizes attainable for single step aqueous silica nanoparticle synthesis.


  • Synthetic multivalency for biological applications

    by Eugene Mahon, Mihail Barboiu

    Current directions and emerging possibilities under investigation for the integration of synthetic and semi-synthetic multivalent architectures with biology are discussed. Attention is focussed around multivalent interactions, their fundamental role in biology, and approaches in emulating them in terms of structure and functionality using synthetic architectures.


  • Biomimetic Approach for Ion Channels Based on Surfactant Encapsulated Spherical Porous Metal‐Oxide Capsules

    by Eugene Mahon, Somenath Garai, Achim Müller, Mihail Barboiu

    Distinguished hybrid clusters with hydrophilic and hydrophobic interiors embedded within cationic surfactant shells are spontaneously inserted into lipid bilayers, showing well-defined ionic conductance behaviors. The transport via the narrow pore gates acting as selectivity filters is controlled by the dehydration energy of the cations.


  • The “Sweet” Side of the Protein Corona: Effects of Glycosylation on Nanoparticle–Cell Interactions

    by Sha Wan, Philip M. Kelly, Eugene Mahon, Henning Stöckmann, Pauline M. Rudd, Frank Caruso, Kenneth A. Dawson, Yan Yan, Marco P. Monopoli

    The significance of a protein corona on nanoparticles in modulating particle properties and their biological interactions has been widely acknowledged. The protein corona is derived from proteins in biological fluids, many of which are glycosylated. To date, the glycans on the proteins have been largely overlooked in studies of nanoparticle–cell interactions. In this study, we demonstrate that glycosylation of the protein corona plays an important role in maintaining the colloidal stability of nanoparticles and influences nanoparticle–cell interactions. The removal of glycans from the protein corona enhances cell membrane adhesion and cell uptake of nanoparticles in comparison with the fully glycosylated form, resulting in the generation of a pro-inflammatory milieu by macrophages. This study highlights that the post-translational modification of proteins can significantly impact nanoparticle–cell interactions by modulating the protein corona properties.


  • Surfactant Titration of Nanoparticle–Protein Corona

    by Daniele Maiolo, Paolo Bergese, Eugene Mahon, Kenneth A. Dawson, Marco P. Monopoli

    Nanoparticles (NP), when exposed to biological fluids, are coated by specific proteins that form the so-called protein corona. While some adsorbing proteins exchange with the surroundings on a short time scale, described as a “dynamic” corona, others with higher affinity and long-lived interaction with the NP surface form a “hard” corona (HC), which is believed to mediate NP interaction with cellular machineries. In-depth NP protein corona characterization is therefore a necessary step in understanding the relationship between surface layer structure and biological outcomes. In the present work, we evaluate the protein composition and stability over time and we systematically challenge the formed complexes with surfactants. Each challenge is characterized through different physicochemical measurements (dynamic light scattering, ζ-potential, and differential centrifugal sedimentation) alongside proteomic evaluation in titration type experiments (surfactant titration). 100 nm silicon oxide (Si) and 100 nm carboxylated polystyrene (PS-COOH) NPs cloaked by human plasma HC were titrated with 3-[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS, zwitterionic), Triton X-100 (nonionic), sodium dodecyl sulfate (SDS, anionic), and dodecyltrimethylammonium bromide (DTAB, cationic) surfactants. Composition and density of HC together with size and ζ-potential of NP–HC complexes were tracked at each step after surfactant titration. Results on Si NP–HC complexes showed that SDS removes most of the HC, while DTAB induces NP agglomeration. Analogous results were obtained for PS NP–HC complexes. Interestingly, CHAPS and Triton X-100, thanks to similar surface binding preferences, enable selective extraction of apolipoprotein AI (ApoAI) from Si NP hard coronas, leaving unaltered the dispersion physicochemical properties. These findings indicate that surfactant titration can enable the study of NP–HC stability through surfactant variation and also selective separation of certain proteins from the HC. This approach thus has an immediate analytical value as well as potential applications in HC engineering.


  • Open Access

    Corrigendum: Highly Selective Li+ Ion Transport by Porous Molybdenum‐Oxide Keplerate‐Type Nanocapsules Integrated in a Supported Liquid Membrane

    by Arnaud Gilles, Simona Mihai, Gihane Nasr, Eugene Mahon, Somenath Garai, Achim Müller, Mihail Barboiu


  • Multivalent Recognition of Concanavalin A by {Mo132} Glyconanocapsules—Toward Biomimetic Hybrid Multilayers

    by Mihail Barboiu, Zineb Mouline, Mihaela Silion, Erol Licsandru, Bogdan C. Simionescu, Eugene Mahon, Mariana Pinteala

    Herein, we consider Müller’s spherical, porous, anionic, molybdenum oxide based capsule, (NH4)42‐ [{(MoVI)MoVI5O21(H2O)6}12{MoV2O4(CH3COO)}30]⋅10 CH3COONH4⋅ 300 H2O≡(NH4)42⋅1 a⋅crystal ingredients≡1, {Mo132}, as an effective sugar‐decorated nanoplatform for multivalent lectin recognition. The ion‐exchange of NH4+ ions of 1 with cationic‐sugars, D‐mannose‐ammonium chloride (2) or D‐glucose‐ammonium chloride (3) results in the formation of glyconanocapsules (NH4)42−n2n⋅1 a and (NH4)42−m3m⋅1 a. The Mannose (NH4)42−n2n⋅1 a capsules bind selectively Concanavalin A (Con A) in aqueous solution, giving an association avidity constant of ${K{{{\rm multi}\hfill \atop {\rm a}\hfill}}}$ =4.6×104 M−1 and an enhancement factor of β=K${{{{\rm multi}\hfill \atop {\rm a}\hfill}}}$ /K${{{{\rm mono}\hfill \atop {\rm ass}\hfill}}}$ =21.9, reminiscent of the formation of “glycoside clusters” on the external surface of glyconanocapsule. The glyconanocapsules (NH4)42−n2n⋅1 a and (NH4)42−m3m⋅1 a self‐assemble in “hybrid multilayers” by successive layer‐by‐layer deposition of (NH4)42−n2n⋅1 a or (NH4)42−m3m⋅1 a and Con A. These architectures, reminiscent of versatile mimics of artificial tissues, can be easily prepared and quantified by using quartz crystal microgravimetry (QCM). The “biomimetic hybrid multilayers” described here are stable under a continual water flow and they may serve as artificial networks for a greater depth of understanding of various biological mechanisms, which can directly benefit the fields of chemical separations, sensors or storage‐delivery devices.


  • Open Access

    Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies

    by K. Zarschler, K. Prapainop, E. Mahon, L. Rocks, M. Bramini, P. M. Kelly, H. Stephan, K. A. Dawson

    For effective localization of functionalized nanoparticles at diseased tissues such as solid tumours or metastases through biorecognition, appropriate targeting vectors directed against selected tumour biomarkers are a key prerequisite. The diversity of such vector molecules ranges from proteins, including antibodies and fragments thereof, through aptamers and glycans to short peptides and small molecules. Here, we analyse the specific nanoparticle targeting capabilities of two previously suggested peptides (D4 and GE11) and a small camelid single-domain antibody (sdAb), representing potential recognition agents for the epidermal growth factor receptor (EGFR). We investigate specificity by way of receptor RNA silencing techniques and look at increasing complexity in vitro by introducing increasing concentrations of human or bovine serum. Peptides D4 and GE11 proved problematic to employ and conjugation resulted in non-receptor specific uptake into cells. Our results show that sdAb-functionalized particles can effectively target the EGFR, even in more complex bovine and human serum conditions where targeting specificity is largely conserved for increasing serum concentration. In human serum however, an inhibition of overall nanoparticle uptake is observed with increasing protein concentration. For highly affine targeting ligands such as sdAbs, targeting a receptor such as EGFR with low serum competitor abundance, receptor recognition function can still be partially realised in complex conditions. Here, we stress the value of evaluating the targeting efficiency of nanoparticle constructs in realistic biological milieu, prior to more extensive in vivo studies.